Skip to Content

Recombitek Equine West Nile Virus (Canada)

This page contains information on Recombitek Equine West Nile Virus for veterinary use.
The information provided typically includes the following:
  • Recombitek Equine West Nile Virus Indications
  • Warnings and cautions for Recombitek Equine West Nile Virus
  • Direction and dosage information for Recombitek Equine West Nile Virus

Recombitek Equine West Nile Virus

This treatment applies to the following species:
Manufacturer: Merial

West Nile Virus Vaccine, Live Canarypox Vector

RECOMBITEK® Equine rWNV

INDICATIONS: This product is recommended for the vaccination of healthy horses as an aid in the prevention of disease, viremia, and encephalitis caused by West Nile Virus.

DOSAGE: Reconstitute the lyophilized vaccine with accompanying liquid diluent and aseptically inject a 1 ml dose by intramuscular route. For primary vaccination, revaccinate with a second 1 ml dose of this product 4 to 6 weeks later. Annual revaccination with a single dose is recommended.

DESCRIPTION:

Contents: RECOMBITEK® Equine West Nile Virus contains a lyophilized recombinant canarypox vectored West Nile Virus vaccine plus a sterile liquid diluent. A canarypox vector has been modified using recombinant technology to express the desired antigens capable of stimulating a protective immune response to West Nile Virus. After inoculation, the vector does not multiply in the horse, but does express the protective proteins. As a consequence, these components induce an immune status against West Nile Virus. Safety and immunogenicity of this vaccine have been demonstrated by vaccination and challenge tests in susceptible horses.

EFFICACY DATA: Immunogenicity of this vaccine has been demonstrated by vaccination and challenge tests in 6 month old healthy horses.

SAFETY DATA: Field Safety testing has demonstrated the Recombitek West Nile Virus Vaccine is safe for use in horses 2 to 4 months of age or older.

PRECAUTIONS: Store at 2-7°C (35-45°F). For the preparation and administration of the vaccine, use sterile and antiseptic-free and/or disinfectant-free material. Burn container and all unused contents. Contains gentamicin as a preservative. Do not vaccinate within 21 days prior to slaughter. As with any vaccine, a hypersensitivity reaction may occur, which may require appropriate symptomatic treatment.

SOLD TO VETERNARIANS ONLY.

Store at 2-7°C (35-45°F).

FOR VETERINARY USE ONLY.

Manufactured By: MERIAL, INC., Athens, GA 30601 USA

U.S. Vet. Lic. No. 298

1-888-Merial-1 (1-888-637-4251)

Distributed In Canada By: MERIAL CANADA, INC., Baie d’Urfé, Qc H9X 4B6

RECOMBITEK is a registered trademark, and the HORSE HEAD Logo is a trademark of Merial.

Made in the USA

Contains

 

Prod. No.

 

10 Doses

10 x 1 Dose (1 mL)

10 x 1 Dose, Lyophilized

10 x 1 mL, Sterile Diluent

2418-10

RM410R6

25 Doses

25 x 1 Dose (1 mL)

25 x 1 Dose, Lyophilized

25 x 1 mL, Sterile Diluent

2418-25

RM3001R4

25 Doses

5 x 5 Dose (5 mL)

5 x 5 Dose, Lyophilized

5 x 5 mL, Sterile Diluent

2418-05

RM1011R4

NAC No.: 11821123

MERIAL CANADA INC.
20000 CLARK GRAHAM, BAIE D'URFÉ, QC, H9X 4B6
Telephone:   514-457-1555
Order Desk:   888-637-4251 (888-MERIAL1)
Fax:   514-457-1175
Website:   www.merial.ca
Email:   service.canada@merial.com
Every effort has been made to ensure the accuracy of the Recombitek Equine West Nile Virus information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the Canadian product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide